JoinTechCell LLC was established in 2013 as a project company of Nearmedic Group. The organization is focused on the development of medical products in the field of cell technologies for use in regenerative medicine.

The flagship product of the company is a separator for obtaining a high-quality cell product – the stromal-vascular fraction of adipose tissue.
Since 2014 JoinTechCell LLC is a resident of the Skolkovo Foundation.

OUR MISSION: Our team works to ensure that innovative cellular technologies are available for every clinic and every patient in Russia.

The company today has the following intellectual property:

1. Patent No. 173796 “Device for fractioning adipose tissue and extracting the stromal vascular fraction therefrom for use in regenerative medicine”.

2. Patent No. 2620304 “Device for isolating cell fractions from human and animal tissues and method for the use thereof”.

3. Patent No. 2697284 “Method for casting a device for fractionation of adipose tissue”.

4. WO 2017/078563 A1 “Device for isolating cell fractions from human and animal tissues and method for the use thereof”.

5. WO 2018/160096 A1 “Device for fractioning adipose tissue and extracting the stromal vascular fraction therefrom for use in regenerative medicine”.

History

  • AUGUST 2019

    Patent granted for invention No. 2697284 “Method for casting a device for fractionation of adipose tissue”.

    ESVIEF and JoinTechCell trademarks registered

  • APRIL 2019

    Launch of the registration of ESVIEF System as a medical device in Russia

  • SEPTEMBER 2018

    The PCT application “Device for fractioning adipose tissue and extracting the stromal vascular fraction therefrom for use in regenerative medicine” was published under the number WO 2018/160096 A1 from 09/07/2018

  • AUGUST 2018

    Approval of the final product for the market – a kit for the isolation of the stromal-vascular fraction “ESVIEF System”, consisting of a separator and collagenase enzyme NB 6

  • JANUARY 2018

    Work has been begun on organizing a full cycle of separator production in Russia

  • SEPTEMBER 2017

    Application of PCT/RU2017/050097 dated 09/29/2017 ” Device for fractioning adipose tissue and extracting the stromal vascular fraction therefrom for use in regenerative medicine”.

    The second Russian patent granted – No. 173796 “Device for fractioning adipose tissue and extracting the stromal vascular fraction therefrom for use in regenerative medicine”

  • MAY 2017

    The first Russian patent granted – No. 2620304 “Device for isolating cell fractions from human and animal tissues and method for the use thereof”.

    The PCT application “Device for isolating cell fractions from human and animal tissues and method for the use thereof” is published under the number WO 2017/078563 A1 from 05/11/2017

  • MARCH 2017

    An application for a Russian patent “Device for fractioning adipose tissue and extracting the stromal vascular fraction therefrom for use in regenerative medicine” has been filed

  • FEBRUARY 2017

    ESVIEF Separator final concept approved

  • NOVEMBER 2015

    The first patent application in Russian and the PCT application “Device for isolating cell fractions from human and animal tissues and method for the use thereof” has been filed

  • AUGUST 2014

    The company received resident status and a minigrant from the Skolkovo Foundation.

    The ESVIEF separator was being developed, a design was selected, and a company development strategy was being formed

  • JULY 2013

    Creation of JoinTechCell LLC

CONTACT INFORMATION

Contact Information

Aviakonstruktora Mikoyana str. 12 125252 Moscow Russia

Write to us

Successfull!

Успешно!